Your browser doesn't support javascript.
loading
ABSTRACT
What is the role of drug interventions in the treatment of patients with covid-19? The latest version of this WHO living guidance focuses on remdesivir, following the 15 October 2020 preprint publication of results from the WHO SOLIDARITY trial. It contains a weak or conditional recommendation against the use of remdesivir in hospitalised patients with covid-19 The first version on this living guidance focused on corticosteroids. The strong recommendation for systemic corticosteroids in patients with severe and critical covid-19, and a weak or conditional recommendation against systemic corticosteroids in patients with non-severe covid-19 are unchanged.
Assuntos

Texto completo: 1 Coleções: 05-specialized Base de dados: BIGG Assunto principal: Corticosteroides / Antirretrovirais / COVID-19 Tipo de estudo: Guideline Idioma: En Revista: BMJ Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 05-specialized Base de dados: BIGG Assunto principal: Corticosteroides / Antirretrovirais / COVID-19 Tipo de estudo: Guideline Idioma: En Revista: BMJ Ano de publicação: 2020 Tipo de documento: Article